Targeted delivery of a cationic dendrimer with a plaque-homing peptide for the treatment of atherosclerosis

References

[1] Libby P . The changing landscape of atherosclerosis. Nature 2021; 592: 524- 33.

[2] Chen W , Schilperoort M , Cao Y , et al. Macrophage-targeted nano-medicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol 2022; 19: 228- 49.

[3] Lee J , Sohn JW , Zhang Y , et al. Nucleic acid-binding polymers as anti-inflammatory agents.Proc Natl Acad Sci USA 2011; 108: 14055- 60.

[4] Wan Q , Huang B , Li T , et al. Selective targeting of visceral adiposity by polycation nanomedicine. Nat Nanotechnol 2022; 17: 1311- 21.

[5] Ruiz-Ojeda M-G , Aguilera P-D . Extracellular matrix remodeling of adipose tissue in obesity and metabolic diseases. Int J Mol Sci 2019; 20: 4888.

[6] Huang B , Wan Q , Li T , et al. Polycationic PAMAM ameliorates obesity-associated chronic inflammation and focal adiposity. Biomaterials 2023; 293: 121850.

[7] Hamzah J , Kotamraju VR , Seo JW , et al. Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2011; 108: 7154- 9.

[8] Song N , Zhao L , Zhu M , et al. Recent progress in LyP-1-based strategies for targeted imaging and therapy. Drug Deliv 2019; 26: 363- 75.

RIGHTS & PERMISSIONS

The Author(s). Published by Oxford University Press on behalf of Higher Education Press.